Objective: To investigate the incidence of pelvic and paraaortic lymph node metastasis in epithelial ovarian cancer. Methods: This was a cross-sectional study. Data were collected from medical records, and from the cancer registry 1539 medical records were obtained. From there, 863 patients were operated and 676 were not, and only 401 medical records were found complete, and 306 samples were excluded because they have been treated with NAC and underwent surgery, patients who underwent surgery but the results is not the epithelium, and patients who underwent surgery, but the results were benign or borderline. And 95 patients who underwent primary surgery and lymphadenectomy only 55 patients have results in lymphadenectomy. This study uses a calculation of sample size with categorial descriptions, with precision of 3% then obtained a minimum sample size of 261 patients. Results: According to the characteristics of the study subjects above, the results were stage I, II, III respectively 60%, 10.9%, and 29%. The metastasized of the lymph node paraaortic 9.1%, and pelvic/paraaortic 20% pelvic/paraaortic23.6%. Based on the degree of differentiation the results were good differentiation 30.9%, moderate differentiation 23.6%, and poor differentiation 45.5%. We found that paraaortic lymph node metastasis were most frequent at stadium III (43.8%). In relationship between lymph node metastasis with differentiation of epithelial ovarian cancer, the most frequent epithelial ovarian cancer were one with poor differentiation in pelvic/paraaortic lymph node with the sum of 69.2%. From analysis, there is significant difference between serous hystologic subtype with mucinosum subtype in pelvic lymph node, significant difference between serous hystologic subtype and clear cell in paraorta or pelvic lymph node and between the serous histology subtype and mucinous as well. Conclusion: Lymph node metastasis incident of ovarian epithelial cancer in paraaorta amounts 20%, pelvic 9.1% and pelvic or paraaortic 23.6%. Higher the stadium, the lymph node involvements will be higher as well (pelvic and paraaortic). In stadium 1 of mucinous subtype with well differentiation has minimal lymph node involvement so we can be more selective in considering the risk and benefit of lymphadenectomy. [Indones J Obstet Gynecol 2018; 6-1: 60-63] 
INTRODUCTION
Ovarian cancer is one of the most common gynecological cancers, after cervical and breast cancers. Ovarian cancer metastasized directly through extention and exfoliation, lymphatic and hematogenous. 1, 2 Stage, cell types, and tumor histological differentiation influence the metastasis of ovarian cancer. 3 Lymphogenic metastasis most commonly found in retroperitoneal pelvic and paraaortic lymph nodes. Lymphogenic spread affects ovarian cancer prognosis. 1, 4 Lymphadenectomy in ovarian cancer is still a controversy. 3, 5 Currently, there is no profound prospective study or randomized controlled trial (RCT) regarding its pathological anatomy, leading to this controversy. 1998 FIGO suggested that pelvic and paraaortic lymphadenectomy are an integrated part that could not be separated during ovarian cancer surgical staging. 6 Studies regarding lymphadenectomy are not profound enough. To date, there are no study published about the incidence of epithelial ovarian cancer lymph node metastasis at Dr. Cipto Mangunkusumo Hospital.
METHODS
This was a cross-sectional study. Data were collected from medical records, and the cancer registry. Of these, 863 patients underwent primary surgery and 676 were not, and only 401 medical records were found complete, and 306 samples were excluded because they have been treated with NAC and underwent surgery, patients who underwent surgery but the results is not the epithelium, and patients who underwent surgery, but the results are benign or borderline. And 95 patients who underwent primary surgery and lymphadenectomy only 55 patients have results in lymphadenectomy. This study uses a calculation of sample size with categorial descriptions, with precision of 3% then obtained a minimum sample size of 261 patients.
RESULTS
1539 medical records were obtained. According to the characteristics of the study subjects above, the results are Stage I, II, III respectively 60%, 10.9%, and 29%. The metastasized of the lymph node paraaortic 9.1%, and pelvic/paraaortic 20% pelvic/paraaortic 23.6%. Based on the degree of differentiation the results were good differentiation 30.9%, moderate differentiation 23.6%, and poor differentiation 45.5%. The association between lymph nodes metastasis and cancer stadium are shown in Table 2 . We found that paraaortic lymph node metastasis were most frequent at stadium III (43.8%) and the least frequent at stadium II (0%). From the statistical analysis we found significant difference in proportion value in pelvic, paraaortic and pelvic/ paraaortic lymph node with higher value in stadium III than stadium I (p<0.05).
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In relationship between lymph node metastasis with differentiation of epithelial ovarian cancer, the most frequent epithelial ovarian cancer were one with poor differentiation in pelvic/paraaortic lymph node with the sum of 69.2% and the least frequent were one well differentiated in pelvic lymph node (0%). From analysis, this study found significant difference in proportion value in paraaortic lymph node between those with poor differentiation compared with moderate differentiation, with p<0.05.
The most common incidence between lymph node metastasis with histologic subtype were shown in Table 2 . Paraortic lymph node with branner histologic type amounts 1 100% because the total of the samples in brenner is only 1, and the second most common is serous hystologic in paraaortic lymph nodes which is 42.9% and the least is mucinosum subtype in pelvic lymph node, amounted to 0%. There was significant difference between serous hystologic subtype with mucinosum subtype in pelvic lymph node, significant difference between serous hystologic subtype and clear cell in paraorta or pelvic lymph node, and between the serous histology subtype and mucinous as well. There were significant differences in the pelvic lymph nodes obstained value higher proportion on serous histological subtype compare with mucinous type (p<0.05) were show in Table 5 , and there were significant differences in the pelvic/ paraaortic lymph node metastases between clear cell histology subtype compared to serous, as well as between serous and mucinous histology subtype. However there were no significant difference in paraaorta lymph node.
DISCUSSION
In this study, we could not reach the minimum sample. From data subject characteristics showed that the spread of ovarian cancer by age at most in the age group 41-50 years by 41.8% this is in accordance with what was found in the literature that increasing age is a major risk factor for developing ovarian cancer, 50% of ovarian cancers diagnosed at the age of 65 years 1, 7 The spread of lymph nodes obtained 23.6%, and the most to the lymph node paraaorta is 20% for deployment on paraaorta through lymphatic channels to follow along infudibulopelvikum ovarian vein and ended up in lymph nodes as high paraaorta renal blood vessels, according to the study. 8, 9 This is in line with a review conducted in the Netherlands M. Kleppe et al (2011) were obtained from 14 studies that incident spread of lymph node on ovarian epithelial cancer was 14.2% (range 6.1-29.6%) where only the lymph node 7.1% and only 2.9 paraaortic % in the pelvic lymph nodes. 3, 10 
CONCLUSIONS
The incidence of lymph node metastasis of ovarian epithelial cancer in paraaorta amounts 20%, pelvic 9.1% and pelvic or paraaortic 23.6%. Higher the stadium, the lymph node involvements will be higher as well (pelvic and paraaortic). In serous subtype, there is more incidents of lymph node involvements (pelvic and paraaortic). If the differentiation type is worse, there will be higher rate of pelvic and paraaortic lymph node involvement. In stadium 1 of mucinous subtype with well differentiation has minimal lymph node involvement so we can be more selective in considering the risk and benefit of lymphadenectomy. Further prospective studies are required to investigate the metastatic factors to lymph node more accurately.
